Michal Piják, MD - Personalised Evolutionary Nutrition,
VYZERÁ TO S REMDESIVIROM ZLE, VEĽMI…
VYZERÁ TO S REMDESIVIROM ZLE, VEĽMI…
Original Investigation Infectious…
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31022-9/fulltext?dgcid=raven_jbs_etoc_email
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31022-9/fulltext?dgcid=raven_jbs_etoc_email
REMDESIVIR DOES NOT SAVE LIVES, DECREASES RECOVERY BY ONLY 4 DAYS, FUNDED BY U.S.
Echos de la recherche • [covid-19] Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled…
Para saborear sem pressa... E também não perguntem nossa opinião por ora. Particularmente para a realidade brasileira, queremos…
Métodos Hicimos un ensayo aleatorizado, doble ciego, controlado con placebo, multicéntrico en diez hospitales en Hubei, China.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31022-9/fulltext
The Lancet publica el artículo: 𝐑𝐞𝐦𝐝𝐞𝐬𝐢𝐯𝐢𝐫 𝐢𝐧 𝐚𝐝𝐮𝐥𝐭𝐬 𝐰𝐢𝐭𝐡 𝐬𝐞𝐯𝐞𝐫𝐞 𝐂𝐎𝐕𝐈𝐃-𝟏𝟗: 𝐚 𝐫𝐚𝐧𝐝𝐨𝐦𝐢𝐬𝐞𝐝, 𝐝𝐨𝐮𝐛𝐥𝐞-𝐛𝐥𝐢𝐧𝐝, 𝐩𝐥𝐚𝐜𝐞𝐛𝐨-𝐜𝐨𝐧𝐭𝐫𝐨𝐥𝐥𝐞𝐝, 𝐦𝐮𝐥𝐭𝐢𝐜…
BEHANDLER VI CORONA FORKERT? Der er to mediciner, som kan afhjælpe Corona-patienter. Det ene hedder "Remdesivir" og er dyrt…
Remdesivir was under trial. The trial failed to meet a satisfactory end. Remdesivir is not a game-changer in reducing the…
重症COVIDに対するレムデシビル、RCT。臨床的改善までの期間は統計的に有意に短縮しなかった。しかし発症後10日以内の患者に限定した解析で、有意差はなかったものの、臨床的改善までの期間はレムデシビル群で短縮する傾向があった。 発症12日以内の肺炎+レムデ…
Remdesivir is not associated with significant clinical benefits in severe COVID-19.
HydroxyChloroquine found to reduce thrombosis + Mainstream is not promoting cheap effective…
In einer chinesischen Studie konnte für Patienten mit schwerer Erkrankung kein eindeutiger Vorteil gezeigt werden. Ein Team um…
Hydroxychloroquine versus…
中国で行われたレムデシベルの比較試験では、効果に優位差なし、重篤な副作用が認められ治験は中止となっています。 アメリカで緊急承認されたから、日本で特例承認ということ問題はないのでしょうか。 https://www.thelancet.com/journal…
Remdesivir: What a study published in the Lancet…
4月29日(水)に, COVID-19に対する効果が期待されている「レムデシビル」に関する3つの大きな発表が立て続けにおこなわれ, 以降同薬剤周辺の話題が騒がしくなってきましたので, 現状をまとめました (長いです…). 1: LANCET 掲載論文 →…
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31022-9/fulltext?dgcid=raven_jbs_etoc_email
COVID-19: Remdesivir zeigt mäßige Wirkung in ersten randomisierten…
A couple of days back, the much-hyped and much-hopeful drug, Remdesivir met a sad end, but according to a study conducted by…
In this study of adult patients admitted to hospital for severe COVID-19, remdesivir was not associated with statistically…
In this study of adult patients admitted to hospital for severe COVID-19, remdesivir was not associated with statistically…
In this study of adult patients admitted to hospital for severe COVID-19, remdesivir was not associated with statistically…
In this study of adult patients admitted to hospital for severe COVID-19, remdesivir was not associated with statistically…
Finalmente o primeiro estudo randomizado e duplo cego. Há esperança.
نتائج تجربة سريرية طال انتظارها على عقار remdesivir (نشرت للتو في مجلة لانسيت). أجريت هذه التجربة على 237 مريض في الصين قسموا عشو…